Deerfield

Deerfield Management Company is a prominent New York City-based investment firm, established in 1994, singularly focused on advancing healthcare. The firm operates with a distinctive three-pillar approach encompassing investment, information, and philanthropy, aiming to drive innovation and improve patient outcomes. Deerfield manages substantial assets, with over $12 billion under management, positioning it as a significant capital provider within the global healthcare ecosystem.

Deerfield's investment strategy is comprehensive, spanning the entire healthcare continuum from early-stage to commercial-stage companies, and across both private and public markets. They deploy various forms of capital, including equity, debt, and structured financing solutions, catering to the diverse needs of biotechnology, pharmaceutical, medical device, diagnostics, and health technology firms. The firm is recognized for its deep sector expertise and its commitment to forging long-term partnerships with companies that are developing groundbreaking solutions to unmet medical needs.

As a major investor, Deerfield frequently leads substantial funding rounds. Their typical first check for private companies often ranges from $25 million to $200 million, with many reported lead investments for Series B and C rounds frequently falling within the $100 million to $150 million range. This significant capital deployment enables companies to progress through critical development phases, including extensive clinical trials and market commercialization. Beyond direct financial investment, Deerfield leverages its Deerfield Institute to provide valuable industry insights and its Deerfield Foundation to engage in philanthropic initiatives, further underscoring its holistic commitment to healthcare advancement.